Related Experiment Videos
LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells
Huang Guo-Wei1, Li Chun-Quan2, Liao Lian-Di3
1Institute of Oncologic Pathology, Shantou University Medical College, Shantou, Guangdong, 515041, PR China; The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou, Guangdong, 515041, PR China; Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, Guangdong, 515041, PR China.
Abstract:
Although Signal transducer and activator of transcription 1 (STAT1)-mediated transactivation potential is inhibited in cancer cells, the mechanism is poorly understood. In the present study, we implicated long non-coding RNA lncRNA625 in the inhibition of STAT1 activity. LncRNA625 knockdown up-regulated STAT1-mediated transcription and resulted in an increase of STAT1-mediated expression of IFITM2. Conversely, lncRNA625 upregulation inhibited STAT1 reporter activity. Mechanistically, lncRNA625 inhibited STAT1 binding to the promoter of IFITM2 in both untreated cells and following interferon-gamma (IFN-γ) stimulation. LncRNA625 interacted with the DNA-binding (DB) domain of STAT1 and promoted STAT1 interaction with T-cell protein tyrosine phosphatase TC45 to dephosphorylate pSTAT1. Taken together, the results show that lncRNA625 inhibits STAT1-mediated transactivation potential by causing formation of STAT1-TC45 complexes, resulting in STAT1 dephosphorylation.
Insights
Long non-coding RNA lncRNA625 inhibits Signal transducer and activator of transcription 1 (STAT1) activity in cancer. LncRNA625 promotes STAT1 dephosphorylation by forming complexes with TC45, reducing STAT1-mediated transcription.
Area of Science:
- Molecular Biology
- Cancer Biology
- RNA Biology
Background:
- Signal transducer and activator of transcription 1 (STAT1) activity is often inhibited in cancer cells, but the underlying mechanisms remain unclear.
- Understanding how STAT1 activity is regulated is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of long non-coding RNA lncRNA625 in regulating STAT1 activity.
- To elucidate the molecular mechanism by which lncRNA625 affects STAT1-mediated transcription.
Main Methods:
- Quantitative real-time PCR to assess gene expression.
- Reporter gene assays to measure STAT1 transcriptional activity.
- Co-immunoprecipitation to study protein-protein interactions.
- Western blotting to detect protein phosphorylation status.
Main Results:
- Knockdown of lncRNA625 led to increased STAT1-mediated transcription and IFITM2 expression.
- Upregulation of lncRNA625 inhibited STAT1 reporter activity.
- LncRNA625 was found to inhibit STAT1 binding to the IFITM2 promoter.
- LncRNA625 interacted with the DNA-binding domain of STAT1 and promoted its interaction with TC45, leading to pSTAT1 dephosphorylation.
Conclusions:
- LncRNA625 acts as a negative regulator of STAT1 activity in cancer cells.
- LncRNA625 inhibits STAT1-mediated transactivation by facilitating STAT1 dephosphorylation via the TC45 phosphatase.
- This mechanism involves the formation of a STAT1-TC45 complex induced by lncRNA625.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...